XML 30 R17.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Stock-Based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Stock-Based Compensation | STOCK-BASED COMPENSATION All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units, relative total stockholder return-based stock awards and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company. Under the Plan, 5,000,000 shares have been authorized for awards. Under the Plan, restricted stock awards (“RSAs”) vest in equal annual installments over a three year period for the RSAs granted after 2020 and a four year period for the RSAs granted in 2020. RSAs granted to non-employee members of the board of directors (“Board Awards”) vest in full on the earlier to occur of the Company’s next Annual Meeting of Stockholders or one year. Performance stock awards (“PSAs”) granted are subject to both time and performance based conditions and vest over a one-to three year period for PSAs granted in 2021 and over a one-to-four year period for PSAs granted in 2020. The amount of such PSAs that will ultimately vest is dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding a specified per share amount for the applicable vesting period. Relative total shareholder return units (“TSR Units”) granted since 2021 are subject to both time and market based conditions and cliff vest after a three-year period. The amount of such market awards that will ultimately vest is dependent on the Company’s total shareholder return (“TSR”) performance relative to a custom TSR peer group consisting of other publicly traded healthcare REITs and will range from 0% to 200% of the TSR Units initially granted. The RSAs, PSAs, and Board Awards are valued on the date of grant based on the closing price of the Company’s common stock, while the TSR Units are valued on the date of grant using a Monte Carlo valuation model. The vesting of certain awards may accelerate, as defined in the grant agreement, upon retirement, a change in control or other events. The following table summarizes the status of the restricted stock award and performance award activity for the year ended December 31, 2023:
| Shares |  | Weighted Average Share Price
Unvested balance at December 31, 2022 | 573,609 |  |  | $ | 20.63 |
Granted: |  |  |
RSAs | 166,122 |  |  | 22.41 |
Board Awards | 24,768 |  |  | 19.38 |
Vested | (185,767) |  |  | 20.94 |
Forfeited | (68,136) |  |  | 20.85 |
Unvested balance at December 31, 2023 | 510,596 |  |  | $ | 21.01 |
As of December 31, 2023, the weighted-average remaining vesting period of such awards was 1.7 years. The following table summarizes the Company’s RSAs and Board Awards grants during the year ended December 31, 2023 (dollars in thousands, except per share amounts):
| Grants |  | Vested
| Shares |  | Weighted Average Share Price |  | Grant Date Fair Value |  | Shares |  | Vest Date Fair Value
During year ended December 31, 2023(1) |  |  |  |  |  |  |  |  |
RSAs | 166,122 |  |  | $ | 22.41 |  |  | $ | 3,722 |  |  | 138,438 |  |  | $ | 2,855 |
PSAs | — |  |  | — |  |  | — |  |  | 21,337 |  |  | 438 |
Board Awards | 24,768 |  |  | 19.38 |  |  | 480 |  |  | 25,992 |  |  | 504 |
(1)The Compensation Committee granted annual awards for 2024 in December 2023. The following table summarizes the Company’s RSA, PSA and Board Award grants during the years ended December 31, 2022 and 2021 (dollars in thousands, except per share amounts):
| Grants
| Shares |  | Weighted Average Share Price |  | Grant Date Fair Value
During year ended December 31, 2022(1) |  |  |  |  |
RSAs | 159,663 |  |  | $ | 19.56 |  |  | $ | 3,123 |
Board Awards | 25,992 |  |  | 16.93 |  |  | 440 |
During year ended December 31, 2021(2) |  |  |  |  |
RSAs | 394,863 |  |  | $ | 21.92 |  |  | $ | 8,654 |
PSAs | 108,414 |  |  | 22.48 |  |  | 2,437 |
Board Awards | 20,266 |  |  | 24.18 |  |  | 490 |
(1)The Compensation Committee granted annual awards for 2023 in December 2022. (2)In 2021, the Compensation Committee changed the structure of the grants that resulted in two long-term equity incentive awards being granted to the Company’s named executive officers in 2021. The Compensation Committee also granted annual awards for 2022 in December 2021. The fair value of the TSR Units is estimated on the date of the grant using a Monte Carlo valuation model. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent weighted average period ending on the grant date for the Company and the selected TSR peer group, and is calculated on a daily basis. The following table reflects the weighted-average key assumptions used in this valuation for awards granted during the years ended December 31, 2023, 2022 and 2021:
| For the Year Ended December 31, 2023 |  | For the Year Ended December 31, 2022 |  | For the Year Ended December 31, 2021
Risk-free interest rate | 4.08 | % |  | 3.91 | % |  | 0.60 | %
Expected stock price volatility | 26.44 | % |  | 52.90 | % |  | 52.42 | %
Expected service period | 3.04 years |  | 3.04 years |  | 2.93 years
Expected dividend yield (assuming full reinvestment) | — | % |  | — | % |  | — | %
Fair value per share at date of grant | $ | 27.41 |  |  | $ | 26.53 |  |  | $ | 29.10 |
The total fair value of the TSR Units granted during the years ended December 31, 2023, 2022 and 2021 was $2.9 million, $2.5 million and $5.3 million, respectively. The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
| For Year Ended December 31,
| 2023 |  | 2022 |  | 2021
Stock-based compensation expense | $ | 5,153 |  |  | $ | 5,758 |  |  | $ | 10,832 |
As of December 31, 2023, there was $10.4 million of unamortized stock-based compensation expense related to the unvested RSAs, PSAs, Board Awards, and TSR Units.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration